All Life sciences articles – Page 2
-
NewsPeople moves: Stratton joins CBRE life sciences transactions team [updated]
PGIM Real Estate names Shen head of agriculture; Spearmint Energy appoints Magnuson CFO
-
NewsVentas US life science and healthcare property fund reaches $2.4bn
Rhode Island Employees Retirement System joins open-ended Vestas fund with $27m commitment
-
NewsAlaska Permanent Fund buys life science asset in Massachusetts for $578m
Sovereign wealth fund also invests €22m in the UK to buy The Glades Shopping Centre in Bromley
-
NewsBarings garners $680m for US life science and technology offices fund
Barings Innovation and Growth Real Estate Fund exceeds $500m target
-
NewsGI Partners swoops on Los Angeles asset for life science and tech-related US fund
GI Real Estate Essential Tech + Science Fund buys 12800 Culver Boulevard asset
-
Special ReportsLife-science real estate: Lab space goes vertical
What does Canary Wharf’s proposed life-sciences tower say about the booming property subsector? Christopher Walker investigates
-
NewsHMC Capital to launch A$1bn healthcare and life sciences vehicle in 2024
ASX‑listed alternative asset manager plans to assemble seed portfolio for yet-to-be-launched fund
-
NewsASX-listed HealthCo REIT buys life science building from Australian Unity Office
HealthCo Healthcare & Wellness REIT buys Eden Park Drive asset in Macquarie Park for A$81m
-
NewsIGIS and CHA Bio form APAC life science real estate investment venture
IGIS also creates Korea Life Science Investment Platform to support venture
-
NewsBA pension and GIC to develop London life science real estate project
BlackRock to manage Tribeca King’s Cross on behalf of BA’s New Airways Pensions Scheme
-
NewsOxford Properties, Novaxia’s French life science JV buys first asset
New JV buys 21,000sqft Biocitech life sciences campus in the Romainville submarket of Paris
-
NewsL&G and Ancora US life science real estate JV secures debut projects
Ancora L&G acquires 387 Technology Circle NW in Atlanta
-
NewsTexas Permanent ups industrial and life science property exposure
Investor commits capital to EQT Exeter and GLP Capital Partners vehicles
-
NewsPSP Investments sells part of £185m UK life science property project to NBIM
NBIM is paying £90.2m for 48.75% stake in 242,000sqft office development at Capital Park in Cambridge
-
NewsUBS AM, Reef launch £2.5bn UK life science real estate development strategy
Build-to-core strategy raises initial £400m and secures four sites in London, Oxford and Cambridge
-
NewsBentallGreenOak, Mission Street UK life science JV buys 23-acre site
Partnership acquires buy site on Coldham’s Lane in Cambridge for new innovation campus
-
NewsBXP expands life science real estate portfolio with $592m purchase
NYSE-listed firm acquires 125 Broadway in Kendall Square in Cambridge, Massachusetts from Biogen
-
NewsRailpen buys £29m life-science business park from AEW
UK railways pension scheme acquires Eastpoint Business Park in Oxford
-
NewsESR makes first life science real estate investment in China
ESR and Chinese joint venture partner acquire Zhangjiang NEO facility in Shanghai for RMB268m
-
NewsGarbe’s life-science fund acquires property in Netherlands
Open-ended Garbe Science and Technology Real Estate Fund buys property at Einsteinweg 5 in Leiden
